Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511Mark H. Norman, Paul E. Hughes, Noel D. D’Angelo et al.|Journal of Medicinal Chemistry|2012Cited by 50
Sequential Metabolism of AMG 487, a Novel CXCR3 Antagonist, Results in Formation of Quinone Reactive Metabolites That Covalently Modify CYP3A4 Cys239 and Cause Time-Dependent Inhibition of the EnzymeKirk R. Henne, Bradley K. Wong, Thuy Tran et al.|Drug Metabolism and Disposition|2012Cited by 42
P450-Mediated O-Demethylated Metabolite Is Responsible for Rat Hepatobiliary Toxicity of Pyridyltriazine-Containing PI3K InhibitorsRaju Subramanian, Hervé Lebrec, Divesh Aidasani et al.|Toxicological Sciences|2014Cited by 7